22 Einträge gefunden

1. Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice

   1. Reinacher-Schick, Anke
   2. Arnold, Dirk
   3. Venerito, Marino
   4. Goekkurt, Eray
   5. Kraeft, Anna-Lena
   6. Seufferlein, Thomas

   2022 - Forschungsinformationssystem des UKE
2. Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur:A Consensus Paper

   1. Wörmann, Bernhard
   2. Bokemeyer, Carsten
   3. Burmeister, Thomas
   4. Köhne, Claus-Henning
   5. Schwab, Matthias
   6. Arnold, Dirk
   7. Blohmer, Jens-Uwe

   2020 - Forschungsinformationssystem des UKE
3. Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

   1. Quidde, Julia
   2. Denne, Laura
   3. Kutscheidt, Andreas
   4. Kindler, Manfred
   5. Kirsch, Andreas
   6. Kripp, Melanie
   7. Petersen, Volker

   2017 - Forschungsinformationssystem des UKE
4. Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

   1. Quidde, Julia
   2. Azémar, Marc
   3. Bokemeyer, Carsten
   4. Arnold, Dirk
   5. Stein, Alexander

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
5. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study

   1. Creutzfeldt, Anna
   2. Suling, Anna
   3. Oechsle, Karin
   4. Mehnert, Anja
   5. Atanackovic, Djordje
   6. Kripp, Melanie
   7. Arnold, Dirk

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
6. Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis

   1. Stein, Alexander
   2. Schwenke, Carsten
   3. Folprecht, Gunnar
   4. Arnold, Dirk

   2016 - Forschungsinformationssystem des UKE
7. A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer

   1. Bokemeyer, Carsten
   2. Stein, Alexander
   3. Ridwelski, Karsten
   4. Atanackovic, Djordje
   5. Arnold, Dirk
   6. Wöll, Ewald
   7. Ulrich, Alexis

   2015 - Forschungsinformationssystem des UKE
8. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial

   1. Stein, Alexander
   2. Arnold, Dirk
   3. Bridgewater, John
   4. Goldstein, David
   5. Jensen, Lars Henrik
   6. Klümpen, Heinz-Josef
   7. Lohse, Ansgar W

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
9. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)

   1. Tachezy, Michael
   2. Gebauer, Florian
   3. Petersen, Cordula
   4. Arnold, Dirk
   5. Trepel, Martin
   6. Wegscheider, Karl
   7. Schafhausen, Philippe

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
10. The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study

    1. Heiss, Markus M
    2. Ströhlein, Michael A
    3. Bokemeyer, Carsten
    4. Arnold, Dirk
    5. Parsons, Simon L
    6. Seimetz, Diane
    7. Lindhofer, Horst

    2014 - Forschungsinformationssystem des UKE
11. Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

    1. Stein, Alexander
    2. Kretzschmar, Albrecht
    3. Behringer, Dirk
    4. Wolff, Thomas
    5. Zimber, Joachim
    6. Hegewisch-Becker, Susanna
    7. Kettner, Erika

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
12. New developments in the second-line treatment of metastatic colorectal cancer: potential place in therapy

    1. Arnold, Dirk
    2. Stein, Alexander

    2013 - Forschungsinformationssystem des UKE
13. Oxaliplatin: a review of approved uses.

    1. Stein, Alexander
    2. Arnold, Dirk

    2012 - Forschungsinformationssystem des UKE
14. PTEN deletion is rare but often homogeneous in gastric cancer.

    1. Mina, Sormeh
    2. Bohn, Benjamin
    3. Simon, Ronald
    4. Krohn, Antje
    5. Reeh, Matthias
    6. Arnold, Dirk
    7. Bokemeyer, Carsten

    2012 - Forschungsinformationssystem des UKE
15. Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option for patients without possibility of peripheral or central venous access.

    1. Stein, Alexander
    2. Hiemer, Sonja
    3. Jordan, Karin
    4. Arnold, Dirk
    5. Schmoll, Hans-Joachim

    2012 - Forschungsinformationssystem des UKE
16. Clinical management of localized colon cancer with capecitabine.

    1. Quidde, Julia
    2. Arnold, Dirk
    3. Stein, Alexander

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
17. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.

    1. Stein, Alexander
    2. Glockzin, Gabriel
    3. Wienke, Andreas
    4. Arnold, Dirk
    5. Edelmann, Thomas
    6. Hildebrandt, Bert
    7. Hollerbach, Stephan

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
18. Personalized treatment of colorectal cancer.

    1. Arnold, Dirk
    2. Stein, Alexander

    2012 - Forschungsinformationssystem des UKE
19. Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.

    1. Piso, Pompiliu
    2. Arnold, Dirk

    2011 - Forschungsinformationssystem des UKE
20. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.

    1. Grimminger, Peter P
    2. Danenberg, Peter
    3. Dellas, Kathrin
    4. Arnold, Dirk
    5. Rödel, Claus
    6. Machiels, Jean-Pascal
    7. Haustermans, Karin

    2011 - Forschungsinformationssystem des UKE